Nikolaos D.
- Country
- Germany
- Department
- 3019: Medizinische Klinik
Research Overview
- Phase 2b Randomized Double‑Blind Dose‑Finding Study of YMI024 on Inflammatory Markers in Adults with Stable Coronary Artery Disease and Elevated hsCRP
- Comparative Efficacy of Inclisiran Sodium Versus Bempedoic Acid in LDL-C Reduction in Atherosclerotic Cardiovascular Disease Patients
- ZENITH: A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Data & Insights
Has run more than one trial at 23 of 498 partner sites.
Specializations
Cardiovascular Medicine
The investigator specializes in managing atherosclerotic cardiovascular disease with a particular focus on innovative lipid-lowering approaches.
- Lipid Management
- Cardiovascular Risk Reduction
- Preventive Cardiology
Expertise includes therapeutic strategies for patients with treatment-resistant hypercholesterolemia.
Metabolic Disorders
Primary research interest centers on lipid disorders and their clinical management through various therapeutic interventions.
- Cholesterol Metabolism
- Lipid-Lowering Therapies
- Metabolic Disease Management
Notable work in evaluating novel approaches to LDL cholesterol reduction in clinical practice.
Therapeutic Innovation
Active involvement in advancing treatment options for patients with cardiovascular disorders through comparative therapeutic studies.
- Novel Drug Evaluation
- Combination Therapy Assessment
- Standard of Care Optimization
Focuses on developing enhanced therapeutic strategies for managing complex cardiovascular conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.